WordNet

discriminating the individual from the generic group or species (同)individualisation, individuation
custom-made clothing
pointedly referring to or concerning a persons individual personality or intimate affairs especially offensively; "unnecessarily personalized remarks"
make or mark or treat as individual; "The sounds were individualized by sharpness and tone" (同)individualise

PrepTutorEJDIC

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2017/07/20 04:57:49」(JST)

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

Canadian Society of Nephrology Commentary on the KDIGO Clinical Practice Guideline for CKD Evaluation and Management.

Akbari A1, Clase CM2, Acott P3, Battistella M4, Bello A5, Feltmate P6, Grill A7, Karsanji M8, Komenda P9, Madore F10, Manns BJ11, Mahdavi S12, Mustafa RA13, Smyth A14, Welcher ES15.
American journal of kidney diseases : the official journal of the National Kidney Foundation.Am J Kidney Dis.2015 Feb;65(2):177-205. doi: 10.1053/j.ajkd.2014.10.013. Epub 2014 Nov 4.
We congratulate the KDIGO (Kidney Disease: Improving Global Outcomes) work group on their comprehensive work in a broad subject area and agreed with many of the recommendations in their clinical practice guideline on the evaluation and management of chronic kidney disease. We concur with the KDIGO d
PMID 25511161

[Genetics and prevention of genetic aortic syndromes (GAS) and of the Marfan syndrome].

von Kodolitsch Y1, Blankart CR, Vogler M, Kallenbach K, Robinson PN.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz.2015 Feb;58(2):146-53. doi: 10.1007/s00103-014-2093-2.
BACKGROUND: Genetic aortic syndromes are autosomal-dominantly heritable aneurysms of the thoracic aorta, which carry a high risk of aortic rupture or acute thoracic aortic dissection at young age.OBJECTIVES: We introduce the reader to the principles of genetic diagnostics and the medical and surgica
PMID 25446311

Current treatment options with immunoglobulin G for the individualization of care in patients with primary immunodeficiency disease.

Jolles S1, Orange JS, Gardulf A, Stein MR, Shapiro R, Borte M, Berger M.
Clinical and experimental immunology.Clin Exp Immunol.2015 Feb;179(2):146-60. doi: 10.1111/cei.12485.
Primary antibody deficiencies require lifelong replacement therapy with immunoglobulin (Ig)G to reduce the incidence and severity of infections. Both subcutaneous and intravenous routes of administering IgG can be effective and well tolerated. Treatment regimens can be individualized to provide opti
PMID 25384609